We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+0.63%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.11B
AUM Growth
+$207M
(+3.5%)
Cap. Flow
+$183M
Cap. Flow
% of AUM
2.99%
Top 10 Holdings %
Top 10 Hldgs %
49.09%
Holding
188
New
51
Increased
37
Reduced
33
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$72.8M |
| 2 |
AutoZone
AZO
|
+$70.8M |
| 3 |
Crocs
CROX
|
+$61M |
| 4 |
Ulta Beauty
ULTA
|
+$58.5M |
| 5 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$51.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Five Below
FIVE
|
+$67.4M |
| 2 |
PTC Therapeutics
PTCT
|
+$64.3M |
| 3 |
Enanta Pharmaceuticals
ENTA
|
+$61.2M |
| 4 |
Burlington
BURL
|
+$60.4M |
| 5 |
Ross Stores
ROST
|
+$42.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.67% |
| 2 | Consumer Discretionary | 7.86% |
| 3 | Consumer Staples | 7.27% |
| 4 | Technology | 5.96% |
| 5 | Communication Services | 1.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
UnitedHealth
UNH
$377B
| – | – |
-100,000
| Closed | -$39.1M |
|
177
Vanda Pharmaceuticals
VNDA
$305M
| – | – |
-1,965,000
| Closed | -$33.7M |
|
178
Voyager Therapeutics
VYGR
$187M
| – | – |
-3,716,000
| Closed | -$9.77M |
|
179
Petco
WOOF
$840M
| – | – |
-366,000
| Closed | -$7.72M |
|
180
Xenetic Biosciences
XBIO
$6.53M
| – | – |
-57,800
| Closed | -$1.19M |
|
181
Xponential Fitness
XPOF
$281M
| – | – |
-886,423
| Closed | -$11.2M |
|
|
HURA
182
TuHURA Biosciences
HURA
$134M
| – | – |
-1,163
| Closed | -$1.75M |
|
|
TBIO
183
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| – | – |
-29,778
| Closed | -$5.97M |
|
|
NUVA
184
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-230,000
| Closed | -$13.8M |
|
|
ARDS
185
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
| – | – |
-1,068,444
| Closed | -$3.93M |
|
|
CYRN
186
DELISTED
CYREN Ltd.
CYRN
| – | – |
-416,667
| Closed | -$5.21M |
|
|
ADMS
187
DELISTED
Adamas Pharmaceuticals
ADMS
| – | – |
-4,000,000
| Closed | -$19.6M |
|
|
ATVI
188
DELISTED
Activision Blizzard
ATVI
| – | – |
-148,000
| Closed | -$11.5M |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Armistice Capital held 188 positions worth $6.11B, up 3.5% from $5.9B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Armistice Capital's Q4 2021 filing shows 51 new, 37 increased, 33 reduced and 43 closed positions. Its largest new stake was AutoZone: 38,024 shares worth $79.7M. The largest sale was Five Below, an estimated $67.4M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Armistice Capital's largest Q4 2021 buy was AutoZone: 38,024 shares worth $79.7M.
- Armistice Capital added most to Jazz Pharmaceuticals in Q4 2021, an estimated $72.8M increase.
- Armistice Capital's biggest Q4 2021 reduction was PTC Therapeutics, cutting an estimated $64.3M.
- Armistice Capital fully exited Five Below in Q4 2021, selling an estimated $67.4M.
- Armistice Capital's ten largest holdings make up 49% of its $6.11B portfolio in Q4 2021.
- Armistice Capital opened 51 new positions and closed 43 in Q4 2021.
- Armistice Capital's portfolio value rose 3.5% quarter-over-quarter to $6.11B.
Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.